Recent developments towards podophyllotoxin congeners as potential apoptosis inducers

Anti-Cancer Agents in Medicinal Chemistry

Volumn 15, Issue 5, 2015, Pages 565-574

  Kamal, Ahmed ^a   Ali Hussaini, Syed Mohammed ^a   Malik, M Shaheer ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Anticancer; Apoptosis; Microtubules; Podophyllotoxin; Topoisomerase

Indexed keywords

4 BETA TRIAZOLYL PODOPHYLLOTOXIN; 4BETA [[4-(PYRROLIDIN 1 YLMETHYL)PHENYL]AMINO] 4 O DEMETHYL 4 EPIPODOPHYLLOTOXIN; CASPASE 3; DEOXYPODOPHYLLOTOXIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; FLUOROURACIL; PODOPHYLLOTOXIN DERIVATIVE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PODOPHYLLOTOXIN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE S PHASE; CHROMATIN; DNA FRAGMENTATION; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; DRUG POTENCY; DRUG STRUCTURE; HUMAN; IC50; MTT ASSAY; NEOPLASM; PODOPHYLLUM; RHIZOME; ANALOGS AND DERIVATIVES; ANIMAL; CELL CYCLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; NEOPLASMS; PATHOLOGY; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; PODOPHYLLOTOXIN;

EID: 84930740474     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520614666141130125623     Document Type: Article

References (43)

1. Xu, H.; Lv, M.; Tian, X. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007. Curr. Med. Chem., 2009, 16(3), 327-349.
2. King, J.L.; Sullivan M. The similarity of the effects of podophyllin and colchicines and their use in the treatment of Codylomata acuminate. Science, 1946, 104(2698), 244-245.
3. Desbene, S.; Giorgi-Renault, S. Drugs that inhibit tubulin polymerization: The particular case of podophyllotoxin and analogues. Curr. Med. Chem., 2002, 2(1), 71-90.
4. Chen, S.W.; Wang, Y.H.; Jin, Y.; Tian, X.; Zheng, Y.-T.; Luo, D.Q.; Tu, Y.Q.: Synthesis and anti-HIV-1 activities of novel podophyllotoxin derivatives. Bioorg. Med. Chem. Lett., 2007, 17(7), 2091-2095.
5. Xu, H.; Xiao, X.: Natural products-based insecticidal agents 4. Semisynthesis and insecticidal activity of novel esters of 2-chloropodophyllotoxin against Mythimna separata Walker in vivo. Bioorg. Med. Chem. Lett., 2009, 19(18), 5415-5418.
6. Canel, C.; Moraes, R. M.; Dayan, F. E.; Ferreira, D. Podophyllotoxin. Phytochemistry, 2000, 54(2), 115-120.
7. Duca, M.; Guianvarc’h, D.; Meresse, P.; Bertounesque, E.; Dauzonne, D.; Kraus-Bertheir, L.; Thirot, S.; Leonce, S.; Pierre, A.; Pfeiffer, B.; Renard, P.; Arimondo, P.B.; Monneret, C.: Synthesis and biological study of a new series of 4’-demethylepipodophyllotoxin derivatives. J. Med. Chem., 2005, 48(2), 593-603.
8. Xiao, Z.; Bastow, K.F.; Vance, J.R.; Sidwell, R.S.; Wang, H.K.; Chen, M.S.; Shi, Q.; Lee, K.H.: Antitumor Agents. 234. Design, synthesis and biological evaluation of novel 4β-[4’’-benzamido-amino]-4’-O-demethyl-epipodophyllotoxin derivatives. J. Med. Chem., 2004, 47(21), 5140-5148.
9. Kamal, A.; Kumar, B.A.; Suresh, P.; Shankaraiah, N.; Kumar, M. S. An efficient one-pot synthesis of benzothiazolo-4β-anilinopodophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity. Bioorg. Med. Chem. Lett., 2011, 21(1), 350-353.
10. Bohlin, L.; Rosen, B. Podophyllotoxin derivatives: Drug discovery and development. Drug Discov. Today, 1996, 1(8), 343-351.
11. Damayanthi, Y.; Lown, J.W. Podophyllotoxins: Current status and recent developments. Curr. Med. Chem. 1998, 5(3), 205-252
12. You, Y.: Podophyllotoxin derivatives: Current synthetic approaches for new anticancer agents. Curr. Pharm. Des., 2005, 11(3), 1695-1717.
13. Kanduc, D.; Mittelman, A.; Serpico, R.; Sinigaglia, E.; Sinha, A. A.; Natale, C.; Santacroce, R.; Di Corcia, M.G.; Lucchese, A.; Dini, L.; Pani, P.; Santacroce, S.; Simone, S.; Bucci, R.; Farber, E. Cell death: Apoptosis versus necrosis (review). Int. J. Oncol., 2002, 21(1), 165-170.
14. Lawen, A.: Apoptosis-an introduction. Bio. Essays, 2003, 25(9), 888-896.
15. Kerr, J.F.R.; Winterford, C.M.; Harmon, B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer, 1994, 73(8), 2013–2026.
16. Jacobson, M.D.; Weil, M.; Raff, M.C. Programmed cell death in animal development. Cell, 1997, 88(3), 347–354.
17. Krammer, P. H. CD95’s deadly mission in the immune system. Nature, 2000, 407(6805), 789-795.
18. Reddy, D.M.; Srinivas, J.; Chashoo, G.; Saxena, A.K.; Kumar, H. M.S. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: Design, synthesis and biological evaluation. Eur. J. Med. Chem., 2011, 46(6), 1983-1991.
19. Zilla, M.K; Nayak, D.; Vishwakarma, R.A.; Sharma, P.R.; Goswami, A.; Ali, A. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α, β-2-propyne podophyllotoxin depicting potent cytotoxic activity. Eur. J. Med. Chem., 2014, 77, 47-55.
20. Jin, Y.; Liu, J.; Huang, W.T.; Chen, S.W.; Hui, L.: Synthesis and biological evaluation of derivatives of 4-deoxypodophyllotoxin as antitumor agents. Eur. J. Med. Chem., 2011, 46(9), 4056-4061.
21. Chen, M.C.; Pan, S.L.; Shi, Q.; Xiao, Z.; Lee, K.H.; Li, T.K.; Tenq, C.M. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells. Cancer Sci., 2012, 103(1), 80-87.
22. Magedov, I.V.; Manpadi, M.; Slambrouck, S.V.; Steelant, W.F.; Rozhkova, E.; Przheval’skii, N.M.; Rogeli, S.; Kornienko, A. Discovery and investigation of antiproliferative and apoptosisinducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis. J. Med. Chem., 2007, 50(21), 5183-5192.
23. Kamal, A.; Kumar, B.A.; Suresh, P.; Agrawal, S.K.; Chashoo, G.; Singh, S.K.; Saxena, A.K. Synthesis of 4β-N-polyaromatic substituted podophyllotoxins: DNA topoisomerase inhibition, anticancer and apoptosis-inducing activities. Bioorg. Med. Chem., 2010, 18(24), 8493-8500.
24. Kamal, A.; Suresh, P.; Ramaiah, M.J.; Srinivasa Reddy, T.; Kapavarapu, R.K.; Rao, B.N.; Imthiajali, S.; Lakshminarayan Reddy, T.; Pushpavalli, S.N.; Shankaraiah, N.; Pal-Bhadra, M. 4β-[4’-(1-(Aryl)ureido)benzamide]podophyllotoxins as DNA topoisomerase I and IIα inhibitors and apoptosis inducing agents. Bioorg. Med. Chem., 2013, 21(17), 5198-5208.
25. Chang, J.Y.; Guo, X.; Chen, H.X.; Jiang, Z.; Fu, Q.; Wang, H.K.; Bastow, K.F.; Zhu, X.K.; Guan, J.; Lee, K.H.; Cheng, Y.C.: Unique biochemical, cytotoxic and antitumor activity of camptothecin and 4β-amino-4'-O-demethylepipodophyllotoxin conjugates. Biochem. Pharmacol., 2000, 59(5), 497-508.
26. Wang, Y.J.; Chen, X.G.; Xiao, Z.Y.; Liu, G.T.; Sun, H. Induction of cell cycle arrest by GL331 via triggering an ATM-dependent DNA damage response in HepG2 cells. J. Asi. Nat. Prod. Res., 2012, 14(7), 657-664.
27. Ren, J.; Wu, L.; Xin, W.Q.; Chen, X.; Hu, K.: Synthesis and biological evaluation of novel 4β-(1,3,4-oxadiazole-2-amino)-podophyllotoxin derivatives. Bioorg. Med. Chem. Lett., 2012, 22(14), 4778-4782.
28. Qi, S.N.; Song, L.J.; Chen, Y.; Jing, Y.X. Reversal of mdr1-mediated multidrug resistance in human leukemia cells by a new spin-labeled derivative of podophyllotoxin. Pharmazie, 2010, 65(2), 117-121.
29. Yang, T.M.; Qi, S.N.; Zhao, N.; Yang, Y.J.; Yuan, H.Q.; Zhang, B.; Jin, S. Induction of apoptosis through caspase-independent or caspase-9-dependent pathway in mouse and human osteosarcoma cells by a new nitroxyl spin-labeled derivative of podophyllotoxin. Apoptosis, 2013, 18(6), 727-738.
30. Huang, W.T.; Liu, J.; Liu, J.F.; Hui, L.; Ding, Y.L.; Chen, S.W. Synthesis and biological evaluation of conjugates of deoxypodophyllotoxin and 5-FU as inducer of caspase-3 and-7. Eur. J. Med. Chem., 2012, 49, 48-54.
31. Sang, C.Y.; Liu, J.F.; Qin, W.W.; Zhao, J.; Hui, L.; Jin, Y.X.; Chen, S.W. Synthesis and evaluation of the apoptosis inducing and CT DNA interaction properties of series of 4β-carbamoyl 4’-O-demethylepipodophyllotoxins. Eur. J. Med. Chem., 2013, 70, 59-67.
32. Xu, D.; Cao, J.; Qian, S.; Li, L.; Hu, C.; Weng, Q.; Lou, J.; Zhu, D.; Zhu, H.; He, Q.; Yang, B. 5k, a novel O-demethylepipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis. Invest. New Drugs, 2011, 29(5), 786-799.
33. Zhao, Y.; Wang, C.; Wu, Z.; Fang, J.; Zhu, L.: Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin. Invest. New Drugs, 2012, 30(1), 17-24.
34. Liu, Y.; Wei, D.; Zhao, Y.; Cheng, W.; Lu, Y.; Ma, Y.; Li, X.; Han, C.; Wei, Y.; Cao, H.; Zhao, C.: Synthesis and biological evaluation of a series of podophyllotoxin derivatives as a class of potent antitutulin agents. Bioorg. Med. Chem., 2012, 20(21), 6285-6295.
35. Zhao, W.; Chen, L.; Li, H.M.; Wang, D.J.; Li, D.S.; Chen, T.; Yuan, Z.P.; Tang, Y.J. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4’-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase IIDNA decatenation. Bioorg. Med. Chem., 2014, 22(11), 2998-3007.
36. Magedov, I.V.; Frolova, L.; Manpadi, M.; Bhoga, U.D.; Tang, H.; Evdokimov, N.M.; George, O.; Georgiou, K.H.; Renner, S.; Getlik, M.; Kinnibrugh, T.L.; Fernandes, M.A.; Van slambrouck, S.; Steelant, W.F.; Shuster, C.B.; Rogelj, S.; Van Otterlo, W.A.; Kornienko, A. Anticancer properties of an important drug lead podophyllotoxin can be efficiently mimicked by diverse heterocyclic scaffolds accessible via one-step synthesis. J. Med. Chem., 2011, 54(12), 4234-4246.
37. Semenova, M.N.; Kiselyov, A.S.; Tsyganov, D.V.; Konyushkin, L. D.; Firgang, S.I.; Semenov, R.V.; Malyshev, O.R.; Raihstat, M. M.; Fuchs, F.; Stielow, A.; Lantow, M.; Philchenkov, A. A.; Zavelevich, M.P.; Zefirov, N.S.; Kuznetsov, S.A.; Semenov, V. V.: Polyalkoxybenzenes from plants. 5. Parsley seed extract in synthesis of azapodophyllotoxins featuring strong tubulin destabilizing activity in the sea urchin embryo and cell culture assays. J. Med. Chem., 2011, 54(20), 7138-7149.
38. Kamal, A.; Mallareddy, A.; Suresh, P.; Nayak, V.L.; Shetti, R.V. C.R.N.C.; Rao, N.S.; Tamboli, J.R.; Shaik, T.B.; Vishnuvardhan, M.V.P.S.; Ramakrishna, S. Synthesis and anticancer activity of 4β-alkylamidochalcone and 4β-cinnamido linked podophyllotoxins as apoptotic inducing agents. Eur. J. Med. Chem., 2012, 47(1), 530-545.
39. Kamal, A.; Suresh, P.; Ramaiah, M.J.; Mallareddy, A.; Imthiajali, S.; Pushpavalli, S.N.; Lavanya, A.; Pal-Bhadra, M. Synthesis and biological evaluation of 4β-sulphonamido and 4β-[(4'-sulphonamido)benzamide]podophyllotoxins as DNA topoisomerase-IIα and apoptosis inducing agents. Bioorg. Med. Chem., 2012, 20(6), 2054-2066.
40. Kamal, A.; Tamboli, J.R.; Vishnuvardhan, M.V.; Adil, S.F.; Nayak, V.L.; Ramakrishna, S.: Synthesis and anticancer activity of heteroaromatic linked 4β-amido podophyllotoxins as apoptotic inducing agents. Bioorg. Med. Chem. Lett., 2013, 23(1), 273-280.
41. Kamal, A.; Tamboli, J.R.; Ramaiah, M.J.; Adil, S.F.; Pushpavalli, S.N.; Ganesh, R.; Sarma, P.; Bhadra, U.; Pal-Bhadra, M.: Quinazolino linked 4β-amidopodophyllotoxin conjugates regulate angiogenic pathway and control breast cancer cell proliferation. Bioorg. Med. Chem., 2013, 21(21), 6414-6426.
42. Kamal, A.; Suresh, P.; Mallareddy, A.; Kumar, B. A.; Reddy, P. V.; Raju, P.; Tamboli, J.R.; Shaik, T.B.; Jain, N.; Kalivendi, S.V.: Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents. Bioorg. Med. Chem., 2011, 19(7), 2349-2358.
43. Kamal, A.; Tamboli, J.R.; Nayak, V.L.; Adil, S.F.; Vishnuvardhan, M.V.P.S.; Ramakrishna, S.: Sunthesis of a terphenyl substituted 4-aza-2,3-didehydropodophyllotoxin analogues as inhibitors of tubulin polymerization and apoptosis inducers. Bioorg. Med. Chem., 2014, 22(9), 2714-2723.